newsfilter
← Latest News
GlobeNewswire·

Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results

  • Legend Biotech will host an investor conference call at 8:00 am ET on Tuesday, May 12, 2026, to review first quarter 2026 financial results.
  • Senior management will provide an overview of quarterly financial performance during the call & accompanying webcast.
  • Investors can access the live audio webcast via a provided weblink, with a replay & earnings press release available on the company website approximately two hours after the call.
  • Legend Biotech operates as the largest standalone cell therapy company with over 2,900 employees.
  • The company markets CARVYKTI, a one-time CAR-T cell therapy treatment for relapsed or refractory multiple myeloma, in collaboration with Johnson & Johnson.
  • Legend Biotech is expanding its leadership to maximize CARVYKTI patient access & plans to drive future innovation across its cell therapy pipeline.
  • Investor contact is Jessie Yeung at (732) 956-8271, & press contact is Kim Fox at (848) 388-8445.